Li Xinfang, Afif Hassan, Cheng Saranette, Martel-Pelletier Johanne, Pelletier Jean-Pierre, Ranger Pierre, Fahmi Hassan
Osteoarthritis Research Unit, Centre hospitalier de l'Université de Montréal, Hôpital Notre-Dame, Montréal, Québec, Canada.
J Rheumatol. 2005 May;32(5):887-95.
Elevated production of prostaglandin E2 (PGE2) plays an important role in the pathogenesis of arthritis. Recently, an inducible microsomal prostaglandin E synthase-1 (mPGES-1) was identified. This enzyme is functionally coupled with cyclooxygenase-2 (COX-2) and converts the COX product PGH2 to PGE2. We analyzed expression of mPGES-1 in human normal and osteoarthritic (OA) cartilage and determined the effect of different inflammatory agonists on the expression of mPGES-1 in OA chondrocytes.
Expression of mPGES-1 mRNA and protein in cartilage was determined by quantitative real-time reverse transcriptase-polymerase chain reaction and immunohistochemistry, respectively. OA chondrocytes were treated with different inflammatory agents, and mPGES-1 protein expression was evaluated by Western blot. Activation of the mPGES-1 promoter was assessed in transient transfection experiments.
Levels of mPGES-1 mRNA and protein were markedly elevated in OA versus normal cartilage. Treatment of chondrocytes with interleukin 1beta (IL-1beta) induced expression of mPGES-1 protein in a dose- and time-dependent manner. This appears to occur at the transcriptional level, as IL-1beta induced expression of mPGES-1 mRNA and the activity of this gene promoter. Tumor necrosis factor-alpha (TNF-alpha) and IL-17 also upregulated expression of mPGES-1 protein and displayed a synergistic effect with IL-1beta. Peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-delta(12,14)-prostaglandin J2 and troglitazone, inhibited IL-1beta-induced mPGES-1 protein expression, an effect that was reversed by exogenous PGE2.
Our study shows that mPGES-1 expression is upregulated in OA versus normal cartilage and that proinflammatory cytokines increased mPGES-1 expression in chondrocytes. These data suggest that mPGES-1 may prove to be an interesting therapeutic target for controlling PGE2 synthesis.
前列腺素E2(PGE2)生成增加在关节炎发病机制中起重要作用。最近,一种诱导型微粒体前列腺素E合酶-1(mPGES-1)被鉴定出来。该酶在功能上与环氧化酶-2(COX-2)偶联,并将COX产物PGH2转化为PGE2。我们分析了mPGES-1在人正常软骨和骨关节炎(OA)软骨中的表达,并确定了不同炎症激动剂对OA软骨细胞中mPGES-1表达的影响。
分别通过定量实时逆转录聚合酶链反应和免疫组织化学法测定软骨中mPGES-1 mRNA和蛋白的表达。用不同炎症因子处理OA软骨细胞,通过蛋白质印迹法评估mPGES-1蛋白表达。在瞬时转染实验中评估mPGES-1启动子的激活情况。
与正常软骨相比,OA软骨中mPGES-1 mRNA和蛋白水平显著升高。用白细胞介素1β(IL-1β)处理软骨细胞以剂量和时间依赖性方式诱导mPGES-1蛋白表达。这似乎发生在转录水平,因为IL-1β诱导mPGES-1 mRNA表达和该基因启动子的活性。肿瘤坏死因子-α(TNF-α)和IL-17也上调mPGES-1蛋白表达,并与IL-1β显示协同作用。过氧化物酶体增殖物激活受体-γ配体、15-脱氧-Δ(12,14)-前列腺素J2和曲格列酮抑制IL-1β诱导的mPGES-1蛋白表达,外源性PGE2可逆转该作用。
我们的研究表明,与正常软骨相比,OA软骨中mPGES-1表达上调,促炎细胞因子增加软骨细胞中mPGES-1表达。这些数据表明,mPGES-1可能被证明是控制PGE2合成的一个有意义的治疗靶点。